Reproducibility of quantifying tracer uptake with PET/CT for evaluation of response to therapy

IEEE Nuclear Science Symposium Conference Record

Volumn 4, Issue , 2007, Pages 2833-2837

  Doot, R K ^a,b   Christian, P E ^c   Mankoff, D A ^b   Kinahan, P E ^a,b  

^a IEEE

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GERMANIUM; IMAGING TECHNIQUES; ITERATIVE METHODS; MERGERS AND ACQUISITIONS; PAINTING; PLASTIC BOTTLES; RANDOM PROCESSES; REPAIR; RESTORATION; SPHERES; STANDARDS; STATISTICS; THREE DIMENSIONAL;

ACTIVITY MEASUREMENTS; AVERAGE VALUES; CIRCULAR REGIONS; DETECTOR SPACING; EPOXY MATRICES; ITERATIVE RECONSTRUCTIONS; NUCLEAR SCIENCES; PET SCANNING; RECOVERY COEFFICIENTS; REPRODUCIBILITY; SIEMENS; SOURCES OF VARIABILITY; STANDARD DEVIATIONS; TOTAL COUNTS;

MEDICAL IMAGING;

EID: 48149107721     PISSN: 10957863     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1109/NSSMIC.2007.4436726     Document Type: Conference Paper

References (7)

1. L. K. Shankar, J. M. Hoffman, S. Bacharach, M. M. Graham, J. Karp, et al., "Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials," J. Nucl. Med., vol. 47, no. 6, pp. 1059-1066, Jun. 2006.
2. W. A. Weber, S. I. Ziegler, R. Thodtmann, A. R. Hanauske, and M. Schwaiger, "Reproducibility of metabolic measurements in malignant tumors using FDG PET," J. Nucl. Med., vol. 40, no. 11, pp. 1771-1777, Nov. 1999.
3. M. Westerterp, J. Pruim, W. Oyen, O. Hoekstra, A. Paans, et al., "Quantification of FDG PET studies using standardised uptake values in multi-centre trials: effects of image reconstruction, resolution and ROI definition parameters," Eur. J. Nucl. Med. Mol. Imaging, vol. 34, no. 3, pp. 392-404, Mar. 2007.
4. N. C. Krak, R. Boellaard, O. S. Hoekstra, J. W. Twisk, C. J. Hoekstra, et al., "Effects of ROI definition and reconstruction method on quantitative outcome and applicability in a response monitoring trial," Eur. J. Nucl. Med. Mol. Imaging, vol. 32, no. 3, pp. 294-301, Mar. 2005.
5. V. Bettinardi, P. Mancosu, M. Danna, G. Giovacchini, C. Landoni, et al., "Two-dimensional vs three-dimensional imaging in whole body oncologic positron emission tomography/computed tomography: a Discovery-STE phantom and patient study," Q. J. Nucl. Med. Mol. Imaging, vol. 51, no. 3, pp. 214-223, Sep. 2007.
6. S. M. Larson, Y. Erdi, T. Akhurst, M. Mazumdar, H. A. Macapinlac, et al., et al., "Tumor Treatment Response Based on Visual and Quantitative Changes in Global Tumor Glycolysis Using PET-FDG Imaging. The Visual Response Score and the Change in Total Lesion Glycolysis," Clin. Positron Imaging, vol. 2, no. 3, pp. 159-171, May 1999.
7. P. E. Kinahan, P. E. Christian, J. S. Karp, C. Divgi, G. Zubal, et al., "A Calibration Phantom for Multi-Center PET/CT Studies of Assessing Response to Therapy," Abstract 662 presented at SNM's 54th Annual meeting in Washington. D.C. on June 6, 2007.